Latest Diabetes: Type II news
Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
posted June 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Efpeglenatide Lowers Risk for Adverse CV Events in T2DM
posted June 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
posted June 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus .jpg)
Recommendations Updated for Management of Anemia in CKD Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
